The role of surgery and fluoroquinolones in the treatment of multidrug-resistant tuberculosis

International Journal of Tuberculosis and Lung Disease

Volumn 11, Issue 9, 2007, Pages 979-985

  Törün, Tülay ^a,b   Tahaoglu K ^a   Ozmen I ^a   Sevim, T ^a   Atac G ^a   Kir, A ^a   Gungor G ^a   Bolukbasi Y ^a   Maden, E ^a  

^a SSK Sureyyapasa Center for Chest Diseases and Thoracic Surgery   (Turkey)

^b Sureyyapasa Gogus ve Kalp Damar Hastaliklari Egitim ve Arastirma Hastanesi   (Turkey)

Author keywords

Fluoroquinolone; Multidrug resistance; Surgery; Tuberculosis

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOSALICYLIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; CAPREOMYCIN; CLARITHROMYCIN; CLOFAZIMINE; CYCLOSERINE; ETHAMBUTOL; KANAMYCIN; OFLOXACIN; PROTIONAMIDE; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFABUTIN; STREPTOMYCIN;

ADJUVANT THERAPY; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; INTERMETHOD COMPARISON; LONG TERM CARE; LUNG LOBECTOMY; LUNG RESECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OPTIMAL DRUG DOSE; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FLUOROQUINOLONES; HUMANS; KAPLAN-MEIERS ESTIMATE; LOGISTIC MODELS; LONG-TERM CARE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 34548721551     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Farmer P. The major infectious diseases in the world - to treat or not to treat? N Engl J Med 2001; 345: 208-210.
2. Goble M, Iseman M D, Madsen L A, Waite D, Ackerson L, Horsburgh C R Jr. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med 1993; 328: 527-532.
3. Telzak E E, Sepkowitz K, Alpert P, et al. Multidrug-resistant tuberculosis in patients without HIV infection. N Eng J Med 1995; 333: 907-911.
4. Yew W W, Chan C K, Chau C H, et al. Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin- containing regimens. Chest 2000; 117: 744-751.
5. Tahaoǧlu K, Törün T, Sevim T, et al. The treatment of multidrug-resistant tuberculosis in Turkey. N Engl J Med 2001; 345: 170-174.
6. Mitnick C, Bayona J, Palacios E, et al. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. N Engl J Med 2003; 348: 119-128.
7. Mukherjee J S, Rich M L, Socci A R, et al. Programmes and principles in treatment of multidrug-resistant tuberculosis. Lancet 2004; 363: 474-481.
8. Leimane V, Riekstina V, Holtz T H, et al. Clinical outcome of individualized treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study. Lancet 2005; 365: 318-326.
9. Chan E D, Laurel V, Strand M J, et al. Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis. Am J Respir Crit Care Med 2004; 169: 1103-1109.
10. Pomerantz B J, Cleveland J C Jr, Olson H K, Pomerantz M. Pulmonary resection for multidrug-resistant tuberculosis. J Thorac Cardiovasc Surg 2001; 121: 448-453.
11. Kir A, İnci İ, Törün T, Atasalihi A, Tahaoǧlu K. Adjuvant resectional surgery improves cure rates in multidrug-resistant tuberculosis. J Thorac Cardiovasc Surg 2006; 131: 695-696.
12. Loddenkemper R, Sagebiel D, Brendel A. Strategies against multidrug-resistant tuberculosis. Eur Respir J 2002; 20 (Suppl 36): 66s-77s.
13. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. WHO/HTM/TB/2006.361. Geneva, Switzerland: WHO, 2006.
14. Park S K, Kim C T, Song S D. Outcome of chemotherapy in 107 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. Int J Tuberc Lung Dis 1998; 2: 877-884.
15. Gosling R D, Uiso L O, Sam N E, et al. The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis. Am J Respir Crit Care Med 2003; 168: 1342-1345.
16. Griffith T D. Treatment of multidrug-resistant tuberculosis: should you try this at home? Am J Respir Crit Care Med 2004; 169: 1082-1083.
17. Törün T, Güngör G, Özmen İ et al. Side effects associated with the treatment of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2005; 9: 1373-1377.